We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$22.1B
1-Year Est. Return
45.54%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
-$178M
(-1.3%)
Cap. Flow
-$1.14B
Cap. Flow
% of AUM
-8.27%
Top 10 Holdings %
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$14.9M |
| 2 |
Palo Alto Networks
PANW
|
+$14.8M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$9.08M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$7.73M |
| 5 |
Crown Holdings
CCK
|
+$5.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$901M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$71.6M |
| 3 |
Apple
AAPL
|
+$11.2M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$10.7M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$8.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.03% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.14% |
| 4 | Consumer Discretionary | 11.03% |
| 5 | Industrials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
1476
DELISTED
Catalyst Pharmaceutical
CPRX
| $702K | 0.01% |
52,200
+1,716
| +3% | +$24.7K |
|
1477
LeMaitre Vascular
LMAT
$1.87B
| $701K | 0.01% |
10,419
+541
| +5% | +$33K |
|
|
MODN
1478
DELISTED
MODEL N, INC.
MODN
| $697K | 0.01% |
19,704
| – | – |
|
1479
NBT Bancorp
NBTB
$2.79B
| $695K | 0.01% |
21,828
| – | – |
|
1480
Sally Beauty Holdings
SBH
$1.54B
| $695K | 0.01% |
56,244
| – | – |
|
|
RDFN
1481
DELISTED
Redfin
RDFN
| $693K | 0.01% |
55,826
| – | – |
|
1482
CTS Corp
CTS
$1.82B
| $692K | 0.01% |
16,241
| – | – |
|
1483
Cars.com
CARS
$661M
| $692K | 0.01% |
34,929
-2,122
| -6% | -$39.9K |
|
1484
Lindsay Corp
LNN
$1.17B
| $690K | 0.01% |
5,785
| – | – |
|
1485
indie Semiconductor
INDI
$980M
| $689K | 0.01% |
73,325
+17,559
| +31% | +$159K |
|
|
VRE
1486
DELISTED
Veris Residential
VRE
| $689K | 0.01% |
42,944
-3,614
| -8% | -$58.4K |
|
1487
Aurinia Pharmaceuticals
AUPH
$2.06B
| $689K | 0.01% |
71,201
| – | – |
|
1488
Krispy Kreme
DNUT
$581M
| $686K | 0.01% |
46,589
+7,991
| +21% | +$120K |
|
1489
BioCryst Pharmaceuticals
BCRX
$2.47B
| $685K | 0.01% |
97,361
| – | – |
|
1490
ZipRecruiter
ZIP
$386M
| $684K | 0.01% |
38,499
-1,540
| -4% | -$25.3K |
|
1491
DraftKings
DKNG
$13B
| $683K | 0.01% |
25,687
+4,243
| +20% | +$97.8K |
|
1492
Veeco
VECO
$3.18B
| $682K | 0.01% |
26,565
| – | – |
|
1493
HNI Corp
HNI
$3.55B
| $682K | 0.01% |
24,189
+2,445
| +11% | +$65K |
|
1494
Procept Biorobotics
PRCT
$1.24B
| $679K | ﹤0.01% |
19,194
+5,396
| +39% | +$178K |
|
1495
Payoneer
PAYO
$2.42B
| $678K | ﹤0.01% |
140,986
+24,364
| +21% | +$122K |
|
1496
Stock Yards Bancorp
SYBT
$2.65B
| $677K | ﹤0.01% |
14,911
| – | – |
|
1497
Trustmark
TRMK
$2.8B
| $676K | ﹤0.01% |
32,029
| – | – |
|
1498
First Commonwealth Financial
FCF
$2.18B
| $676K | ﹤0.01% |
53,454
| – | – |
|
1499
Matthews International
MATW
$722M
| $676K | ﹤0.01% |
15,858
| – | – |
|
|
LADR
1500
Ladder Capital
LADR
$1.27B
| $675K | ﹤0.01% |
62,231
+2,120
| +4% | +$20.5K |
|
Similar funds
BA
FAM
VARA
EIM
HHII
JG
MetLife Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.
- MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
- MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
- MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
- MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
- MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
- MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
- MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.
Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.